Patent: 9,695,242

✉ Email this page to a colleague

Summary for Patent: 9,695,242

Scope and claims summary:

Title:	Bispecific EGFR/c-Met antibodies
Abstract:	Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.
Inventor(s):	Chiu Mark, Moores Sheri, Neijssen Joost, Parren Paul, Schuurman Janine
Assignee:	Janssen Biotech, Inc.
Application Number:	US15386195
Patent Claims:	see list of patent claims

Details for Patent 9,695,242

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	RYBREVANT	amivantamab-vmjw	Injection	761210	May 21, 2021	⤷ Subscribe	2036-12-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.